{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:39:29Z","timestamp":1769600369098,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["NS078287"],"award-info":[{"award-number":["NS078287"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["NS099623"],"award-info":[{"award-number":["NS099623"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["U54NS065712"],"award-info":[{"award-number":["U54NS065712"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuromol Med"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s12017-019-08564-4","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T13:15:22Z","timestamp":1567084522000},"page":"68-72","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Incidence and Clinical Features of TRPV4-Linked Axonal Neuropathies in a USA Cohort of Charcot\u2013Marie\u2013Tooth Disease Type 2"],"prefix":"10.1007","volume":"22","author":[{"given":"Sheng","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawna M. E.","family":"Feely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luna","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teepu","family":"Siddique","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0030-8465","authenticated-orcid":false,"given":"Han-Xiang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Shy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,29]]},"reference":[{"key":"8564_CR1","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ng.508","volume":"42","author":"M Auer-Grumbach","year":"2010","unstructured":"Auer-Grumbach, M., et al. (2010). Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C. Nature Genetics,42, 160\u2013164. \nhttps:\/\/doi.org\/10.1038\/ng.508\n\n.","journal-title":"Nature Genetics"},{"key":"8564_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/ng.509","volume":"42","author":"HX Deng","year":"2010","unstructured":"Deng, H. X., et al. (2010). Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4. Nature Genetics,42, 165\u2013169. \nhttps:\/\/doi.org\/10.1038\/ng.509\n\n.","journal-title":"Nature Genetics"},{"key":"8564_CR3","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/jnc.14217","volume":"143","author":"MF Dohrn","year":"2017","unstructured":"Dohrn, M. F., et al. (2017). Frequent genes in rare diseases: Panel-based next generation sequencing to disclose causal mutations in hereditary neuropathies. Journal of Neurochemistry,143, 507\u2013522. \nhttps:\/\/doi.org\/10.1111\/jnc.14217\n\n.","journal-title":"Journal of Neurochemistry"},{"key":"8564_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/mgg3.126","volume":"3","author":"AP Drew","year":"2015","unstructured":"Drew, A. P., et al. (2015). Improved inherited peripheral neuropathy genetic diagnosis by whole-exome sequencing. Molecular Genetics & Genomic Medicine,3, 143\u2013154. \nhttps:\/\/doi.org\/10.1002\/mgg3.126\n\n.","journal-title":"Molecular Genetics & Genomic Medicine"},{"key":"8564_CR5","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1212\/WNL.0000000000000450","volume":"82","author":"A Echaniz-Laguna","year":"2014","unstructured":"Echaniz-Laguna, A., et al. (2014). Phenotypic spectrum and incidence of TRPV4 mutations in patients with inherited axonal neuropathy. Neurology,82, 1919\u20131926. \nhttps:\/\/doi.org\/10.1212\/WNL.0000000000000450\n\n.","journal-title":"Neurology"},{"key":"8564_CR6","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1136\/jnnp-2012-303055","volume":"83","author":"KA Fawcett","year":"2012","unstructured":"Fawcett, K. A., et al. (2012). Comprehensive analysis of the TRPV4 gene in a large series of inherited neuropathies and controls. Journal of Neurology, Neurosurgery and Psychiatry,83, 1204\u20131209. \nhttps:\/\/doi.org\/10.1136\/jnnp-2012-303055\n\n.","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"8564_CR7","doi-asserted-by":"publisher","first-page":"17281","DOI":"10.1074\/jbc.m111.237685","volume":"286","author":"F Fecto","year":"2011","unstructured":"Fecto, F., et al. (2011). Mutant TRPV4-mediated toxicity is linked to increased constitutive function in axonal neuropathies. Journal of Biological Chemistry,286, 17281\u201317291. \nhttps:\/\/doi.org\/10.1074\/jbc.m111.237685\n\n.","journal-title":"Journal of Biological Chemistry"},{"key":"8564_CR8","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1136\/jnnp-2011-300285","volume":"83","author":"C Foley","year":"2012","unstructured":"Foley, C., et al. (2012). Charcot-Marie-Tooth disease in Northern England. Journal of Neurology, Neurosurgery and Psychiatry,83, 572\u2013573. \nhttps:\/\/doi.org\/10.1136\/jnnp-2011-300285\n\n.","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"8564_CR9","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.nmd.2013.05.005","volume":"23","author":"B Gess","year":"2013","unstructured":"Gess, B., Schirmacher, A., Boentert, M., & Young, P. (2013). Charcot-Marie-Tooth disease: Frequency of genetic subtypes in a German neuromuscular center population. Neuromuscular Disorders,23, 647\u2013651. \nhttps:\/\/doi.org\/10.1016\/j.nmd.2013.05.005\n\n.","journal-title":"Neuromuscular Disorders"},{"key":"8564_CR10","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1212\/wnl.0b013e31820f2de3","volume":"76","author":"CJ Klein","year":"2011","unstructured":"Klein, C. J., et al. (2011). TRPV4 mutations and cytotoxic hypercalcemia in axonal Charcot-Marie-Tooth neuropathies. Neurology,76, 887\u2013894. \nhttps:\/\/doi.org\/10.1212\/wnl.0b013e31820f2de3\n\n.","journal-title":"Neurology"},{"key":"8564_CR11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ng.512","volume":"42","author":"G Landoure","year":"2010","unstructured":"Landoure, G., et al. (2010). Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C. Nature Genetics,42, 170\u2013174. \nhttps:\/\/doi.org\/10.1038\/ng.512\n\n.","journal-title":"Nature Genetics"},{"key":"8564_CR12","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1136\/jnnp-2012-302451","volume":"83","author":"SM Murphy","year":"2012","unstructured":"Murphy, S. M., et al. (2012). Charcot-Marie-Tooth disease: Frequency of genetic subtypes and guidelines for genetic testing. Journal of Neurology, Neurosurgery and Psychiatry,83, 706\u2013710. \nhttps:\/\/doi.org\/10.1136\/jnnp-2012-302451\n\n.","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"8564_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/cge.12594","volume":"89","author":"S Rudnik-Schoneborn","year":"2016","unstructured":"Rudnik-Schoneborn, S., et al. (2016). Diagnostic algorithms in Charcot-Marie-Tooth neuropathies: Experiences from a German genetic laboratory on the basis of 1206 index patients. Clinical Genetics,89, 34\u201343. \nhttps:\/\/doi.org\/10.1111\/cge.12594\n\n.","journal-title":"Clinical Genetics"},{"key":"8564_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ana.22166","volume":"69","author":"AS Saporta","year":"2011","unstructured":"Saporta, A. S., et al. (2011). Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Annals of Neurology,69, 22\u201333. \nhttps:\/\/doi.org\/10.1002\/ana.22166\n\n.","journal-title":"Annals of Neurology"},{"key":"8564_CR15","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/brain\/awy208","volume":"141","author":"ME Shy","year":"2018","unstructured":"Shy, M. E. (2018). Reply: The classification of Charcot-Marie-Tooth diseases, a never-ending story: CMT4? Brain: A Journal of Neurology,141, e71. \nhttps:\/\/doi.org\/10.1093\/brain\/awy208\n\n.","journal-title":"Brain: A Journal of Neurology"},{"key":"8564_CR16","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1212\/WNL.0b013e3182a9f56a","volume":"81","author":"R Sivera","year":"2013","unstructured":"Sivera, R., et al. (2013). Charcot-Marie-Tooth disease: Genetic and clinical spectrum in a Spanish clinical series. Neurology,81, 1617\u20131625. \nhttps:\/\/doi.org\/10.1212\/WNL.0b013e3182a9f56a\n\n.","journal-title":"Neurology"},{"key":"8564_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1399-0004.1974.tb00638.x","volume":"6","author":"H Skre","year":"1974","unstructured":"Skre, H. (1974). Genetic and clinical aspects of Charcot-Marie-Tooth\u2019s disease. Clinical Genetics,6, 98\u2013118.","journal-title":"Clinical Genetics"},{"key":"8564_CR18","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1093\/brain\/awl126","volume":"129","author":"K Verhoeven","year":"2006","unstructured":"Verhoeven, K., et al. (2006). MFN2 mutation distribution and genotype\/phenotype correlation in Charcot-Marie-Tooth type 2. Brain: A Journal of Neurology,129, 2093\u20132102. \nhttps:\/\/doi.org\/10.1093\/brain\/awl126\n\n.","journal-title":"Brain: A Journal of Neurology"},{"key":"8564_CR19","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1093\/brain\/awq109","volume":"133","author":"M Zimon","year":"2010","unstructured":"Zimon, M., et al. (2010). Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies. Brain,133, 1798\u20131809. \nhttps:\/\/doi.org\/10.1093\/brain\/awq109\n\n.","journal-title":"Brain"}],"container-title":["NeuroMolecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-019-08564-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12017-019-08564-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-019-08564-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T23:28:07Z","timestamp":1598570887000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12017-019-08564-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,29]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["8564"],"URL":"https:\/\/doi.org\/10.1007\/s12017-019-08564-4","relation":{},"ISSN":["1535-1084","1559-1174"],"issn-type":[{"value":"1535-1084","type":"print"},{"value":"1559-1174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,29]]},"assertion":[{"value":"21 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Michael E. Shy is a consultant for Alnylam, Inflectis, and Acceleron.\u00a0The other authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was obtained from the University of Iowa (Iowa City, IA) and University of Wisconsin (UW; Madison, WI), and written informed assent\/consent was provided by participants under a protocol approved by the ethics board of the NIH Rare Diseases Clinical Research Network (Protocol INC6611).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Written informed consent was obtained from all participants involved in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}